Budapest, Hungary

Lajos Gyorgy

This inventor holds 2 USPTO granted patents. Top assignee: Egyt Gyogyszervegyeszeti Gyar. Active years: 1976-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lajos Gyorgy. Retrieved from https://idiyas.com/inventor/lajos-gyorgy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1976-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lajos Gyorgy: Innovator in Isoquinoline Derivatives

Introduction

Lajos Gyorgy is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of chemistry, particularly in the development of isoquinoline derivatives. With a total of 2 patents, his work has implications in various applications within the pharmaceutical industry.

Latest Patents

Lajos Gyorgy's latest patents include innovative compounds such as new 4-aryl-2-methyl-1,2,3,4-tetrahydro-isoquinoline derivatives. These compounds are represented by the general Formula I and their salts. Additionally, he has developed 1,4-Dihydro-3(2H)-isoquinolinone derivatives, which are characterized by specific chemical formulas that enhance their utility in medicinal chemistry.

Career Highlights

Lajos Gyorgy is currently employed at Egyt Gyogyszervegyeszeti Gyar, where he continues to push the boundaries of chemical research. His work has been instrumental in advancing the understanding and application of isoquinoline derivatives in various therapeutic contexts.

Collaborations

Lajos has collaborated with esteemed colleagues such as Gyula Deak and Margit Doda. Their combined expertise has fostered a productive research environment, leading to innovative discoveries in their field.

Conclusion

Lajos Gyorgy stands out as a prominent figure in the realm of chemical innovation, particularly with his contributions to isoquinoline derivatives. His patents reflect a commitment to advancing pharmaceutical science, and his collaborations further enhance the impact of his work.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…